Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018
Authors
Keywords
-
Journal
Psychiatry Investigation
Volume 16, Issue 1, Pages 50-58
Publisher
Korean Neuropsychiatric Association
Online
2019-01-24
DOI
10.30773/pi.2018.12.21.1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
- (2018) Anish Shah et al. Annals of General Psychiatry
- A 6-Year Posttreatment Follow-up of Panic Disorder Patients
- (2017) Rafael C. Freire et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy
- (2017) Saskia Deppermann et al. NeuroImage-Clinical
- Effect of single doses of pindolol and d-fenfluramine on flumazenil-induced anxiety in panic disorder patients
- (2017) M. Bernik et al. BEHAVIOURAL BRAIN RESEARCH
- Vortioxetine: a New Treatment for Major Depressive Disorder
- (2016) K. Ryan Connolly et al. EXPERT OPINION ON PHARMACOTHERAPY
- Aripiprazole as Augmentation Treatment of Refractory Generalized Anxiety Disorder and Panic Disorder
- (2016) Elizabeth A. Hoge et al. CNS SPECTRUMS
- Treatment–resistant panic disorder: a systematic review
- (2015) Rafael C. Freire et al. EXPERT OPINION ON PHARMACOTHERAPY
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder
- (2015) Andrew W. Goddard et al. Annals of General Psychiatry
- Current Pharmacological Interventions in Panic Disorder
- (2014) Rafael Freire et al. CNS & Neurological Disorders-Drug Targets
- PANIC DISORDER AND AGORAPHOBIA: AN OVERVIEW AND COMMENTARY ON DSM-5 CHANGES
- (2014) Gordon J. G. Asmundson et al. DEPRESSION AND ANXIETY
- Novel investigational therapeutics for panic disorder
- (2014) Giampaolo Perna et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Anticonvulsant medications for panic disorder: a review and synthesis of the evidence
- (2013) Nash N. Boutros et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression
- (2012) Antonio Mantovani et al. JOURNAL OF AFFECTIVE DISORDERS
- Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial
- (2012) Kwan-Woo Choi et al. Clinical Psychopharmacology and Neuroscience
- Emerging drugs for panic disorder
- (2011) Giampaolo Perna et al. EXPERT OPINION ON EMERGING DRUGS
- New treatment options for panic disorder: clinical trials from 2000 to 2010
- (2011) Rafael C Freire et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder
- (2011) Charles Merideth et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The Efficacy and Safety of Alprazolam Versus Other Benzodiazepines in the Treatment of Panic Disorder
- (2011) Steven Moylan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Naturalistic, Parallel-Group Study for the Long-Term Treatment of Panic Disorder With Clonazepam or Paroxetine
- (2011) Antonio E. Nardi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
- (2011) Benny Bang-Andersen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Slow vs standard up-titration of paroxetine in the treatment of panic disorder: A prospective randomized trial
- (2010) Massimiliano Buoli et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study
- (2009) James M Prosser et al. BMC Psychiatry
- Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
- (2009) Borwin Bandelow et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder
- (2009) Antonio E. Nardi et al. PSYCHIATRY RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More